Results
2
Companies with a Future performance score of at least 3, ordered by Future performance score.
2 companies
Kamada
Market Cap: ₪1.4b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪24.10
7D
-1.6%
1Y
26.2%
Can-Fite BioPharma
Market Cap: ₪50.1m
A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.
CANF
₪0.013
7D
0%
1Y
-53.6%